|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of Aerva lanata on cisplatin and gentamicin models of acute renal failure 显示文摘 | Shirwaikar A Issac D Malini S | 2004 | J Ethnopharmacol2004，90，： | 1 |
| 2 | Spectral Repeat Finder(SRF):Identification of Repetitive Sequences Using Fourier Transformation显示文摘 | Sharma D Issac B Raghava G P S | 2004 | Bioinformatics2004，20，9： | 1 |
| 3 | Reinfored concrete pile formulas 显示文摘 | Issacs D V | 1931 | Transaction of the Institution of Engineers Austral- ia1931，，： | 1 |
| 4 | Ciprofloxacin resistant in epidemic methicillin-resistant Staphylococcus aureurs 显示文摘 | Issacs R D Kunke P I Cohen R L | 1998 | Lancet1998，1，8585： | 1 |
| 5 | Rate ofchangeload balancing in distributed and parallel system显示文摘 | Luis Miguel Campos Issac D Scherson | 2002 | Parallel Computing2002，，2： | 1 |
| 6 | Mycoplasma pneumoniae infections in Australian children显示文摘 | Othman N Issacs D Kesson A | 2005 | J Peadiatr Child Health2005，41，12： | 1 |
| 7 | Differential out?come of infection with attenuated Salmonella in MyD88-deficient mice is dependent on the route of administration 显示文摘 | Issac J M Sarawathiamma D AI-Ketbi M 1 | 2013 | Immunohiolo?gy2013，218，1： | 1 |
| 8 | Reinfored concrete pile formulas显示文摘 | ISSACS D V | 1931 | Transaction of the Institution of Engineers Australia1931，，： | 1 |
| 9 | Endometiral thickness is a valod monitoring parameter in cycles of ovulation induction with menotropins alone显示文摘 | Issacs J D Wells C S William D B et a1 | 1996 | Fertil Steril1996，65，： | 1 |
| 10 | Structural requirements for thioester bond formation in human complement component C3:reassessment of therole of thioester bond integrity on the conformation of C3显示文摘 | Issac L Isenman D E | 1992 | The Journal of Biological Chemistry1992，267，10： | 1 |
| 11 | Transaction of the Institution of Engineers显示文摘 | Issacs D V Reinforced concrete pile formulas | | 0，，： | 1 |
| 12 | Ultrafast charge separation at CdS quantum dot/rhoda- mine B molecule interface 显示文摘 | BOULESBAA A ISSAC A STOCKWELL D | 2007 | Journal of the American Chemical Society2007，129，15： | 1 |
| 13 | Endometrial thickness is a valid monitoring parameter in cycles of ovula- tion induction with menotropins alone显示文摘 | ISSACS J D WELLS C S WILLIAM D B | 1996 | Fertility and Sterility1996，65，2： | 1 |
| 14 | Solubility of mixtures of H2S and CO2 in a monoethanolamine solution at low partial pressures显示文摘 | Issacs E E Otto F D Mather A E | 1980 | Journal of Chemical and Engineering Data1980，25，2： | 1 |
| 15 | Abundance of pelagic fish during the 19th and 20th centuries as recorded in anaerobic sediment off the Californias显示文摘 | Soutar A Issacs J D | 1974 | Fish Bull1974，72，： | 1 |
| 16 | Autibiotic prophylaxis of pancreatic infection in pationts with necrotizing pancreatitis ratienale evidence and recommendations显示文摘 | Issac Moyshenyoot Me Ephraim Mandell M D ScottFenner M D | 2006 | current Gastroenrology Reperts2006，8，2： | 1 |
| 17 | 水痘疫苗显示文摘本文在回顾水痘减毒活疫苗的发展及其应用现状的基础上,叙述了该疫苗对健康儿童及白血病患儿的免疫效果和安全性,并就其前景做了展望。 | Issacs D 何立民 | 1991 | 国外医学(预防.诊断.治疗用生物制品分册)1991，14，2： | 0 |
| 18 | Health-related quality-of-life and health-utility reporting in critical care显示文摘Mortality is a well-established patient-important outcome in critical care studies.In contrast,morbidity is less uniformly reported(given the myriad of critical care illnesses and complications of each)but may have a common end-impact on a patient’s functional capacity and health-related quality-of-life(HRQoL).Survival with a poor quality-of-life may not be acceptable depending on individual patient values and preferences.Hence,as mortality decreases within critical care,it becomes increasingly important to measure intensive care unit(ICU)survivor HRQoL.HRQoL measurements with a preference-based scoring algorithm can be converted into health utilities on a scale anchored at 0(representing death)and 1(representing full health).They can be combined with survival to calculate quality-adjusted life-years(QALY),which are one of the most widely used methods of combining morbidity and mortality into a composite outcome.Although QALYs have been use for health-technology assessment decision-making,an emerging and novel role would be to inform clinical decision-making for patients,families and healthcare providers about what expected HRQoL may be during and after ICU care.Critical care randomized control trials(RCTs)have not routinely measured or reported HRQoL(until more recently),likely due to incapacity of some patients to participate in patient-reported outcome measures.Further differences in HRQoL measurement tools can lead to non-comparable values.To this end,we propose the validation of a gold-standard HRQoL tool in critical care,specifically the EQ-5D-5L.Both combined health-utility and mortality(disaggregated)and QALYs(aggregated)can be reported,with disaggregation allowing for determination of which components are the main drivers of the QALY outcome.Increased use of HRQoL,health-utility,and QALYs in critical care RCTs has the potential to:(1)Increase the likelihood of finding important effects if they exist;(2)improve research efficiency;and(3)help inform optimal management of critically ill patients allowing for decision-making about their HRQoL,in additional to traditional health-technology assessments. | Vincent Issac Lau Jeffrey A Johnson Sean M Bagshaw Oleksa G Rewa John Basmaji Kimberley A Lewis M Elizabeth Wilcox Kali Barrett Francois Lamontagne Francois Lauzier Niall D Ferguson Simon J W Oczkowski Kirsten M Fiest Daniel J Niven Henry T Stelfox Waleed Alhazzani Margaret Herridge Robert Fowler Deborah J Cook Bram Rochwerg Feng Xie | 2022 | World Journal of Critical Care Medicine2022，11，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员